Literature DB >> 24390259

[Association between mesenteric phlebosclerosis and Chinese herbal medicine intake].

Kensei Ohtsu1, Toshiyuki Matsui, Taku Nishimura, Fumihito Hirai, Keisuke Ikeda, Akinori Iwashita, Makoto Yorioka, Sadamune Hatakeyama, Toshio Hoashi, Yuki Koga, Toshihiro Sakurai, Masaki Miyaoka.   

Abstract

BACKGROUND: Mesenteric phlebosclerosis (MP) is a relatively rare disease of the colon. An association between MP and Chinese herbal medicine intake has recently been recognized. SUBJECTS AND METHODS: In the present study, we investigated the association between MP and Chinese herbal medicine intake in 42 patients, including those reported in the literature as well as those treated by us.
RESULTS: Approximately 90% patients treated by us reported a history of Chinese herbal medicine intake, particularly kamishoyosan, orengedokuto, and sanshishi (gardeniae fructus), the lattermost being consumed by the majority of patients as a crude herbal medicine. DISCUSSION: Several MP patients report a history of Chinese herbal medicine intake. Furthermore, symptoms are exacerbated in MP patients who continue to consume the medicine after onset. Interestingly, MP was reported to develop in a married couple who had consumed the same Chinese herbal medicine for a prolonged period. These findings suggest that the intake of Chinese herbal medicine, particularly sanshishi, is strongly associated with MP development.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24390259

Source DB:  PubMed          Journal:  Nihon Shokakibyo Gakkai Zasshi        ISSN: 0446-6586


  8 in total

1.  Mesenteric phlebosclerosis associated with the oral intake of Japanese traditional (Kampo) medicines containing Gardeniae Fructus.

Authors:  Etsuko Hisanaga; Takaaki Sano; Keigo Sato; Shiko Kuribayashi; Toshio Uraoka
Journal:  Clin J Gastroenterol       Date:  2021-08-02

2.  Idiopathic mesenteric phlebosclerosis: one case report and systematic literature review of 240 cases.

Authors:  Jialiang Wang; Jun Shao; Helei Lu; Bingyi Wang; Ji Chen
Journal:  Am J Transl Res       Date:  2021-11-15       Impact factor: 4.060

3.  Idiopathic mesenteric phlebosclerosis associated with herbal drugs presenting with asymptomatic fecal occult blood.

Authors:  Yosuke Sasaki; Manabu Saito; Yumi Koshiba; Hiroaki Zai; Yoshihisa Urita
Journal:  J Gen Fam Med       Date:  2017-07-17

4.  Effects of Long-Term Administration of Gardeniae Fructus on Intra-Abdominal Organs of Rats.

Authors:  Hisato Takei; Seiichi Iizuka; Masahiro Yamamoto
Journal:  Evid Based Complement Alternat Med       Date:  2020-06-08       Impact factor: 2.629

5.  Search of anti-allodynic compounds from Plantaginis Semen, a crude drug ingredient of Kampo formula "Goshajinkigan".

Authors:  Kazufumi Toume; Zhiyan Hou; Huanhuan Yu; Mitsuru Kato; Miki Maesaka; Yanjing Bai; Shiho Hanazawa; Yuewei Ge; Tsugunobu Andoh; Katsuko Komatsu
Journal:  J Nat Med       Date:  2019-06-12       Impact factor: 2.343

6.  Idiopathic mesenteric phlebosclerosis associated with long-term oral intake of geniposide.

Authors:  Yang Wen; You-Wei Chen; Ai-Hong Meng; Ming Zhao; Song-Hua Fang; Yan-Qing Ma
Journal:  World J Gastroenterol       Date:  2021-06-14       Impact factor: 5.742

7.  Mesenteric phlebosclerosis with amyloidosis in association with the long-term use of medicinal liquor: A case report.

Authors:  Yi-Bing Hu; Min-Li Hu; Jin Ding; Qun-Ying Wang; Xiao-Yun Yang
Journal:  World J Clin Cases       Date:  2020-02-26       Impact factor: 1.337

Review 8.  Adverse Effects of Kampo Medicines.

Authors:  Yutaka Shimada
Journal:  Intern Med       Date:  2021-02-08       Impact factor: 1.271

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.